Veracyte Inc

NASDAQ:VCYT 4:00:00 PM EDT

19.37

-0.86 (-4.25%)

7:25:17 PM EDT: $20.33 +0.96 (+4.96%)

Market Cap (Intraday)	1.45B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$93.37 Million
Adjusted EPS	-$0.16

See more estimates

10-Day MA	$20.52
50-Day MA	$22.68
200-Day MA	$24.53

See more pivots

Veracyte Inc Stock, NASDAQ:VCYT

6000 Shoreline Court, Suite 300, South San Francisco, California 94080

United States of America

Phone: +1.650.243.6300

Number of Employees: 815

http://www.veracyte.com

Description

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.